Barbara L. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Barbara L. Smith has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Michele A. Gadd
Division of Breast Surgery, Mass General Brigham, Boston, USA
21 shared publicationsMichelle C. Specht
Division of Breast Surgery, Mass General Brigham, Boston, USA
19 shared publicationsBridget N. Kelly
Division of Surgical Oncology, Massachusetts General Hospital, Boston, USA
9 shared publicationsFrancys C. Verdial
Division of Breast Surgery, Mass General Brigham, Boston, USA
9 shared publicationsRong Tang
Division of Surgical Oncology, Massachusetts General Hospital, MGH Center for Breast Cancer, Boston, USA
9 shared publicationsSuzanne B. Coopey
Division of Surgical Oncology, Massachusetts General Hospital, Boston, USA
9 shared publications
Latest Publications
- 23 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-2
ASO Author Reflections: Patient-Reported Outcomes Following Pegulicianine Fluorescence-Guided Surgery
- 23 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-2
ASO Author Reflections: Patient-Reported Outcomes Following Pegulicianine Fluorescence-Guided Surgery
- 19 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10994
ASO Visual Abstract: Multi-agent Preemptive Analgesia Reduces Pain and Shortens Hospital Stay after Mastectomy with Reconstruction
- 19 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10994
ASO Visual Abstract: Multi-agent Preemptive Analgesia Reduces Pain and Shortens Hospital Stay after Mastectomy with Reconstruction
- Open Access
- 17 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-9
Does Additional Margin Excision During Pegulicianine Fluorescence-Guided Surgery (pFGS) Affect Patient Breast Satisfaction?
Background: Use of pegulicianine fluorescence-guided surgery (pFGS) for intraoperative residual tumor assessment in breast cancer lumpectomy surgery removed additional tumor and reduced second surgeries. This study assessed breast satisfaction among patients with and without additional margin excision and preference for optimizing cosmesis versus avoiding a second surgery. Methods: Two clinical trials randomized stages 0 to 3 breast cancer patients to pFGS or standard lumpectomy. For pFGS, additional cavity margin specimens were taken at sites of pegulicianine fluorescence after standard lumpectomy. Surveys of BREAST-Q satisfaction were administered in trials 1 and 2, and surveys of cancer worry and patient preference information (PPI) were administered in trial 2. Results: Satisfaction surveys were completed 6 to 12 months postoperatively by 14 % of the trial 1 and 67 % of the trial 2 patients. The mean postoperative breast satisfaction score was 75.8 ( n = 99; range, 15–100) for the pegulicianine-assisted arm patients versus 79.0 ( n = 19; range, 35–100) for the control subjects ( p = 0.53). The mean breast satisfaction score was 73.6 ( n = 52; range, 33–100) among the patients with additional pFGS-assisted cavity margins taken versus 78.5 ( n = 66; range, 15–100) ( p = 0.17) among those with no additional tissue taken. Overall, 70.6 % of the respondents strongly preferred or preferred avoiding a second surgery, 19.6 % had no preference, and only 9.8 % preferred to optimize cosmetic outcomes. No patient strongly preferred to optimize cosmetic outcomes Conclusions: No decrease in breast satisfaction was observed among the breast cancer lumpectomy patients undergoing pFGS intraoperative margin assessment despite additional tissue removal. Most of the patients valued avoiding a second surgery over maximizing cosmetic outcome.
- 17 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-9
Open AccessDoes Additional Margin Excision During Pegulicianine Fluorescence-Guided Surgery (pFGS) Affect Patient Breast Satisfaction?
Background: Use of pegulicianine fluorescence-guided surgery (pFGS) for intraoperative residual tumor assessment in breast cancer lumpectomy surgery removed additional tumor and reduced second surgeries. This study assessed breast satisfaction among patients with and without additional margin excision and preference for optimizing cosmesis versus avoiding a second surgery. Methods: Two clinical trials randomized stages 0 to 3 breast cancer patients to pFGS or standard lumpectomy. For pFGS, additional cavity margin specimens were taken at sites of pegulicianine fluorescence after standard lumpectomy. Surveys of BREAST-Q satisfaction were administered in trials 1 and 2, and surveys of cancer worry and patient preference information (PPI) were administered in trial 2. Results: Satisfaction surveys were completed 6 to 12 months postoperatively by 14 % of the trial 1 and 67 % of the trial 2 patients. The mean postoperative breast satisfaction score was 75.8 ( n = 99; range, 15–100) for the pegulicianine-assisted arm patients versus 79.0 ( n = 19; range, 35–100) for the control subjects ( p = 0.53). The mean breast satisfaction score was 73.6 ( n = 52; range, 33–100) among the patients with additional pFGS-assisted cavity margins taken versus 78.5 ( n = 66; range, 15–100) ( p = 0.17) among those with no additional tissue taken. Overall, 70.6 % of the respondents strongly preferred or preferred avoiding a second surgery, 19.6 % had no preference, and only 9.8 % preferred to optimize cosmetic outcomes. No patient strongly preferred to optimize cosmetic outcomes Conclusions: No decrease in breast satisfaction was observed among the breast cancer lumpectomy patients undergoing pFGS intraoperative margin assessment despite additional tissue removal. Most of the patients valued avoiding a second surgery over maximizing cosmetic outcome.
- 17 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10979-10980
ASO Author Reflections: Decreased Pain, Shorter Hospital Stay: The Impact of Preemptive Analgesia for Mastectomy with Reconstruction
- 17 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10979-10980
ASO Author Reflections: Decreased Pain, Shorter Hospital Stay: The Impact of Preemptive Analgesia for Mastectomy with Reconstruction
- Open Access
- 16 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-2
ASO Visual Abstract: Does Additional Margin Excision During Pegulicianine Fluorescence-Guided Surgery (pFGS) Affect Patient Breast Satisfaction?
- 16 October 2026
- Published by Springer Nature in Annals of Surgical Oncology
- p. 1-2
Open AccessASO Visual Abstract: Does Additional Margin Excision During Pegulicianine Fluorescence-Guided Surgery (pFGS) Affect Patient Breast Satisfaction?
- 20 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10878-10885
Multi-agent Preemptive Analgesia Reduces Pain and Shortens Hospital Stay After Mastectomy with Reconstruction
- 20 August 2026
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 33 (13) , 10878-10885
Multi-agent Preemptive Analgesia Reduces Pain and Shortens Hospital Stay After Mastectomy with Reconstruction
- 12 August 2026
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 218 (3) , 40
When immunotherapy hurts: neoadjuvant PD-1 inhibitors increase opioid use after mastectomy with reconstruction
- 12 August 2026
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 218 (3) , 40
When immunotherapy hurts: neoadjuvant PD-1 inhibitors increase opioid use after mastectomy with reconstruction
- Open Access
- 20 January 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3348
Correction: Sentinel Node Mapping with Blue Dye Injection after Lumpectomy Specimen Removal: Implications for Fluorescence-Guided Breast Surgery
- 20 January 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3348
Open AccessCorrection: Sentinel Node Mapping with Blue Dye Injection after Lumpectomy Specimen Removal: Implications for Fluorescence-Guided Breast Surgery
- Open Access
- 14 December 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3062-3064
Sentinel Node Mapping with Blue Dye Injection after Lumpectomy Specimen Removal: Implications for Fluorescence-Guided Breast Surgery
- 14 December 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3062-3064
Open AccessSentinel Node Mapping with Blue Dye Injection after Lumpectomy Specimen Removal: Implications for Fluorescence-Guided Breast Surgery
- 28 May 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (8) , 1-2
ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia
- 28 May 2024
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 31 (8) , 1-2
ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia